002252 Shanghai RAAS Blood Products
- 7.90
- +0.53+7.19%
Shanghai RAAS Blood Products News
Shanghai Rice: Record of Investor Relations Activities for September 26, 2024
Shanghai Rice: 2024 Semi-Annual Equity Distribution Implementation Notice
Shanghai Rice: Investor Relations Activity Record Form for September 13, 2024
Shanghai Rice: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders
Shanghai Rice: Announcement on the completion of the non-transactional transfer of the reserved shares of the first phase of the employee stock ownership plan
Shanghai Laishi: Legal Opinion of Beijing Zhonglun (Shanghai) Law Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Shanghai Laishi Blood Products Co., Ltd.
Shanghai Rice: Investor Relations Activity Record Form for August 28, 2024
Shanghai Laishi: Semi-annual non-operating capital usage and other related capital transactions summary table
Shanghai Rice: Semi-Annual Report 2024
Shanghai Rice: 2024 Semi-Annual Financial Report
Shanghai Laishi: Semi-Annual Report Board Resolution Announcement
Shanghai Rice: Announcement on the 2024 Mid-Term Profit Distribution Plan
Shanghai Rice: Special Report on the Deposit and Use of Funds Raised for the Semi-Annual Year 2024
Shanghai Laishi: Semi-Annual Report Supervisory Board Resolutions Announcement
Shanghai Rice: Summary of the 2024 Semi-Annual Report
Shanghai Laishi: Written review opinions of the board of supervisors on matters related to the second meeting of the 6th board of supervisors
Shanghai Laishi: Semi-Annual Financial Report
Shanghai RAAS Blood Products: Announcement of Completion of Remaining Stock Repurchase Cancellation and Share Changes
Shanghai RAAS Blood Products: Notice on convening the third extraordinary shareholder meeting in 2024.
Shanghai RAAS Blood Products: Company bylaws (August 2024)
Analysis
Price Target
No Data
No Data